Article 83 requires each Member State to designate a national contact point. Article 84 sets the Agency and Commission roles in supporting the cooperation between Member States. Article 85 establishes the Clinical Trials Coordination and Advisory Group (CTAG), composed of representatives of the national contact points, advising the Commission and the Member States on the application of the Regulation.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.